Cargando…

Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies

OBJECTIVES: Given the spread of multidrug-resistant tuberculosis (MDR-TB), new therapies are urgently needed, including the repurposing of existing drugs. We aimed to assess key considerations for the clinical and programmatic use of clofazimine (Cfz), a riminophenazine with antimycobacterial activi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Thomas J, Dotsenko, Svetlana, Jafarov, Azizkhon, Weyer, Karin, Falzon, Dennis, Lunte, Kaspars, Nunn, Paul, Jaramillo, Ernesto, Keshavjee, Salmaan, Wares, Douglas F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Global Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902362/ https://www.ncbi.nlm.nih.gov/pubmed/24384902 http://dx.doi.org/10.1136/bmjopen-2013-004143

Ejemplares similares

Multidrug-resistant tuberculosis around the world: what progress has been made?
por: Falzon, Dennis, et al.
Publicado: (2015)

Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility
por: Lunte, Kaspars, et al.
Publicado: (2015)

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
por: Hwang, Thomas J., et al.
Publicado: (2014)

The Role of Novel Approaches and New Findings in the Pharmacology of Tuberculosis Medicines in Improving Treatment Outcomes
por: Falzon, Dennis, et al.
Publicado: (2018)

Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023)

Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts
por: Brooks, Meredith B., et al.
Publicado: (2018)

2260. Clofazimine Safety and Efficacy for Treatment of Multidrug-Resistant Non-Tuberculous Mycobacteria (NTM)
por: Alameer, Reem, et al.
Publicado: (2019)

Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy
por: Nicholson, Thomas, et al.
Publicado: (2016)

Identifying barriers and facilitators to implementation of community-based tuberculosis active case finding with mobile X-ray units in Lima, Peru: a RE-AIM evaluation
por: Yuen, Courtney M, et al.
Publicado: (2021)

Improved outcomes following addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis
por: Yao, Ge, et al.
Publicado: (2023)

Clofazimine-induced Hair Pigmentation
por: Philip, Mariam, et al.
Publicado: (2012)

Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis
por: Montezuma, Thais, et al.
Publicado: (2023)

Clofazimine for Rapidly Growing Mycobacterial Infections
por: Carey, George B, et al.
Publicado: (2017)

Clofazimine induced methemoglobinemia – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022)

Clofazimine induced pigmentation in leprosy patches
por: Chavhan, Samiksha Deepak, et al.
Publicado: (2022)

Extemporaneously compounded liquid formulations of clofazimine
por: Taneja, R., et al.
Publicado: (2023)

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
por: Sonnenkalb, Lindsay, et al.
Publicado: (2023)

Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China
por: Zheng, Huiwen, et al.
Publicado: (2021)

Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study
por: Li, Rong, et al.
Publicado: (2023)

The Global Drug Facility as an intervention in the market for tuberculosis drugs
por: Arinaminpathy, Nimalan, et al.
Publicado: (2015)

Clofazimine-induced enteropathy in a patient of leprosy
por: Singh, Harminder, et al.
Publicado: (2013)

Clofazimine-induced premaculopathy in a vitiliginous patient
por: Kasturi, Nirupama, et al.
Publicado: (2016)

Clofazimine for Treatment of Mycobacterium abscessus Infections in Children
por: Adler-Shohet, Felice C, et al.
Publicado: (2017)

Clofazimine-induced methemoglobinemia: A rare incidence
por: Asif, Ahmed, et al.
Publicado: (2018)

Clofazimine pharmacokinetics in patients with TB: dosing implications
por: Abdelwahab, Mahmoud Tareq, et al.
Publicado: (2020)

Clofazimine: A Promising Inhibitor of Rabies Virus
por: Wu, Jiajing, et al.
Publicado: (2021)

Role of Clofazimine in Treatment of Mycobacterium avium Complex
por: Nasiri, Mohammad Javad, et al.
Publicado: (2021)

Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries
por: Kim, Jungyeon, et al.
Publicado: (2019)

Trends, patterns and health consequences of multimorbidity among South Korea adults: Analysis of nationally representative survey data 2007-2016
por: Kim, Jungyeon, et al.
Publicado: (2020)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche
por: McGuffin, Sarah A, et al.
Publicado: (2017)

Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
por: Anderson, Ronald, et al.
Publicado: (2018)

Novel Administration of Clofazimine for the Treatment of Mycobacterium avium Infection
por: Valinetz, Ethan, et al.
Publicado: (2020)

Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
por: Zhang, Lei, et al.
Publicado: (2023)

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
por: Falzon, Dennis, et al.
Publicado: (2017)

Integrating Sexual and Reproductive Health Services Within HIV Services: WHO Guidance
por: Ford, Nathan, et al.
Publicado: (2021)

Advancing the science of health research capacity strengthening in low-income and middle-income countries: a scoping review of the published literature, 2000–2016
por: Dean, Laura, et al.
Publicado: (2017)

Supporting a Comprehensive International Approach to Global Tuberculosis Eradication Is the Right Thing to Do
por: Burzynski, Joseph, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6k5ofs88l14dtri52hmtg6ntlq